IRADIMED CORP current report, 28 January 2015

IRADIMED CORP Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by IRADIMED CORPORATION on January 28, 2015. The report discloses a material event regarding the resumption of domestic shipments for the company's DERS option.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on operational status rather than financial performance data.

Material Changes

The primary material change reported is the resumption of domestic shipments for the DERS option, as announced in a press release dated January 28, 2015.

Guidance, Outlook, and Risks

The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the operational update. The report incorporates a press release by reference as Exhibit 99.1.

Investor Verification Checklist

  • Verify the details of the DERS option shipment resumption in the attached press release (Exhibit 99.1).
  • Confirm if the resumption of shipments impacts the company's revenue recognition timeline.
  • Review subsequent filings for any financial impact resulting from this operational change.